PPC
LLY icon

Park Place Capital’s Eli Lilly LLY Stock Holding History

Park Place Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$967K Sell
806
-40
-5% -$40.9K 0.15% 93
2026
Q1 		$778K Buy
846
+162
+24% +$164K 0.16% 88
2025
Q4 		$735K Buy
684
+7
+1% +$6.69K 0.15% 94
2025
Q3 		$517K Sell
677
-156
-19% -$116K 0.11% 119
2025
Q2 		$646K Sell
833
-954
-53% -$741K 0.15% 104
2025
Q1 		$1.48M Sell
1,787
-39
-2% -$32.5K 0.4% 55
2024
Q4 		$1.41M Sell
1,826
-56
-3% -$46.4K 0.39% 56
2024
Q3 		$1.67M Sell
1,882
-466
-20% -$419K 0.48% 45
2024
Q2 		$2.13M Sell
2,348
-444
-16% -$355K 0.68% 33
2024
Q1 		$2.17M Sell
2,792
-246
-8% -$175K 0.78% 29
2023
Q4 		$1.77M Sell
3,038
-3
-0.1% -$1.75K 0.71% 30
2023
Q3 		$1.63M Buy
3,041
+496
+19% +$256K 0.48% 45
2023
Q2 		$1.19M Sell
2,545
-943
-27% -$395K 0.34% 65
2023
Q1 		$1.2M Buy
3,488
+429
+14% +$145K 0.34% 67
2022
Q4 		$1.12M Buy
+3,059
New +$1.08M 0.32% 76

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Park Place Capital's LLY Position: Q2 2026 in Review

Park Place Capital reduced its Eli Lilly (LLY) stake by 4.7% in Q2 2026, selling an estimated $40.9K and leaving 806 shares worth $967K. The position accounts for 0.15% of the portfolio, ranked #93.

Park Place Capital first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.17M in Q1 2024. 4,637 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Park Place Capital held 806 shares of Eli Lilly worth $967K as of Q2 2026.
  • Park Place Capital sold 40 Eli Lilly shares in Q2 2026, an estimated $40.9K.
  • Eli Lilly made up 0.15% of Park Place Capital's portfolio in Q2 2026, its #93 holding.
  • Park Place Capital first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • Park Place Capital's Eli Lilly position peaked at $2.17M in Q1 2024.
  • 4,637 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.